Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23891)

• Formulation Name: Selumetinib 10 mg capsule
• Company: Astrazeneca Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Selumetinib	(DMC7W6R)	Melanoma	2C30	Phase 3

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ammonium hydroxide	(E00687)	Not Available	Alkalizing agent
Carrageenan	(E00714)	Not Available	Emulsion stabilizing agent; Gelling agent; Microencapsulating agent; Modified-release agent; Suspending agent; Viscosity-controlling agent
Ferric oxide black	(E00522)	16211978	Colorant
Hypromellose	(E00634)	Not Available	Coating agent
Potassium chloride	(E00074)	4873	Tonicity agent
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Shellac	(E00695)	Not Available	Coating agent; Film/membrane-forming agent; Microencapsulating agent; Modified-release agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Tocophersolan	(E00679)	Not Available	Antioxidant; Binding agent; Emulsifying agent; Ointment base; Solubilizing agent; Surfactant; Suspending agent
Water	(E00035)	962	Solvent